項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Operating income | 2,125,538 | 3,806,614 | 3,767,782 |
Operating cost | 1,630,786 | 2,994,623 | 2,960,385 |
Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
Operating gross profit (loss) | 494,752 | 811,991 | 807,397 |
Unrealized profit (loss) on sales of goods | - | - | - |
Realized profit (loss) on sales of goods | - | - | - |
Operating gross profit (loss), net | 494,752 | 811,991 | 807,397 |
Operating expenses | 106,259 | 194,252 | 181,020 |
Other gain (loss), net | 2,781 | 7,240 | 5,783 |
Operating profit (loss) | 391,274 | 624,979 | 632,160 |
Non-operating income and expenses | 51,078 | 92,808 | 47,400 |
Net profit (loss) before tax | 442,352 | 717,787 | 679,560 |
Income tax expense (benefits) | 87,316 | 136,787 | 133,621 |
Net profit (loss) of ongoing business for the current period | 355,036 | 581,000 | 545,939 |
Profit (loss) of closed units | - | - | - |
Profit (loss) of non-jointly controlled equity before merger | - | - | - |
Net profit (loss) for the current period | 355,036 | 581,000 | 545,939 |
Other comprehensive profit (loss), net | 1,093 | -7,844 | -13,469 |
Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
Total comprehensive profit and loss for the current period | 356,129 | 573,156 | 532,470 |
Net profit (loss) attributable to owners of parent company | 355,036 | 581,000 | 545,939 |
Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Net profit (loss) attributable to non-controlling interests | - | - | - |
Comprehensive profit (loss) attributable to owners of parent company | 356,129 | 573,156 | 532,470 |
Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
Basic earnings per share (yuan) | 1 | 3 | 3 |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Net cash inflow (outflow) from operating activities | 1,147,260 | 1,181,372 | 1,467,031 |
Net cash inflows (outflows) from investing activities | -780,729 | -821,431 | -1,408,988 |
Net cash inflow (outflow) from financing activities | -490,051 | -286,915 | -273,797 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
Increase (decrease) in cash and cash equivalents in the current period | -123,520 | 73,026 | -215,754 |
Beginning balance of cash and cash equivalents | 1,113,611 | 1,040,585 | 1,256,339 |
Ending balance of cash and cash equivalents | 990,091 | 1,113,611 | 1,040,585 |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Current asset | 5,500,137 | 5,106,309 | 4,870,845 |
Non-current asset | 5,663,321 | 5,419,131 | 4,828,056 |
Total asset | 11,163,458 | 10,525,440 | 9,698,901 |
Current liability | 4,456,891 | 3,838,116 | 3,324,180 |
Non-current liability | 3,370,879 | 3,214,084 | 3,175,436 |
Total liability | 7,827,770 | 7,052,200 | 6,499,616 |
share capital | 1,828,450 | 1,828,450 | 1,662,227 |
Equity - secruity token | - | - | - |
capital reserve | - | - | - |
retained earning | 1,324,706 | 1,463,351 | 1,347,493 |
Other equity | 182,532 | 181,439 | 189,565 |
Treasury stock | - | - | - |
Total equity attributable to owners of parent company | 3,335,688 | 3,473,240 | 3,199,285 |
Equity attributable to former owner of business combination under common control | - | - | - |
Equity attributable to non-controlling interest before business merger under common control | - | - | - |
Non-controlling interests | - | - | - |
Total Equity | 3,335,688 | 3,473,240 | 3,199,285 |
Share capital awaiting retirement (unit: share) | - | - | - |
Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
Net asset value per share | 18 | 19 | 19 |